Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
61
BSX Quote, Financials, Valuation and Earnings
Last price:
$97.73
Seasonality move
:
9.7%
Day range:
$97.64 - $99.34
52-week range:
$85.98 - $109.50
Dividend yield:
0%
P/E ratio:
52.72x
P/S ratio:
7.61x
P/B ratio:
6.25x
Volume:
9.9M
Avg. volume:
8.6M
1-year change:
8.95%
Market cap:
$146.1B
Revenue:
$16.7B
EPS (TTM):
$1.87
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp.
|
$5B | $0.71 | 15.72% | 105.56% | $126.48 |
|
ABT
Abbott Laboratories
|
$11.4B | $1.30 | 7.5% | -71.7% | $144.43 |
|
ELUT
Elutia, Inc.
|
$6.7M | -- | -43.31% | -- | $4.00 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.4B | $1.99 | 12.86% | 18.99% | $592.96 |
|
SOLV
Solventum Corp.
|
$2.1B | $1.43 | -5.45% | 768.77% | $84.36 |
|
WST
West Pharmaceutical Services, Inc.
|
$789.9M | $1.71 | 6.25% | 3.19% | $346.07 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp.
|
$98.57 | $126.48 | $146.1B | 52.72x | $0.00 | 0% | 7.61x |
|
ABT
Abbott Laboratories
|
$125.29 | $144.43 | $217.9B | 15.72x | $0.59 | 1.88% | 5.00x |
|
ELUT
Elutia, Inc.
|
$0.65 | $4.00 | $27.6M | -- | $0.00 | 0% | 1.31x |
|
ISRG
Intuitive Surgical, Inc.
|
$569.71 | $592.96 | $202B | 75.41x | $0.00 | 0% | 21.55x |
|
SOLV
Solventum Corp.
|
$85.25 | $84.36 | $14.8B | 9.81x | $0.00 | 0% | 1.77x |
|
WST
West Pharmaceutical Services, Inc.
|
$284.31 | $346.07 | $20.5B | 42.11x | $0.22 | 0.3% | 6.86x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BSX
Boston Scientific Corp.
|
33.99% | 0.345 | 8.31% | 0.81x |
|
ABT
Abbott Laboratories
|
20.25% | 0.426 | 5.99% | 1.12x |
|
ELUT
Elutia, Inc.
|
-717.99% | 0.059 | 101.77% | 0.20x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.065 | -- | 3.42x |
|
SOLV
Solventum Corp.
|
50.75% | 0.962 | 40.57% | 0.94x |
|
WST
West Pharmaceutical Services, Inc.
|
9.03% | 1.397 | 1.61% | 2.02x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp.
|
$3.3B | $1B | 8.19% | 12.46% | 20.55% | $1.2B |
|
ABT
Abbott Laboratories
|
$5.9B | $2.2B | 22.49% | 29.06% | 19.03% | $2.3B |
|
ELUT
Elutia, Inc.
|
$1.9M | -$4.4M | -- | -- | -131.06% | -$3.5M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.7B | $759.7M | 16.35% | 16.38% | 30.33% | $735.6M |
|
SOLV
Solventum Corp.
|
$1.1B | $171M | 13.6% | 42.2% | 8.16% | -$21M |
|
WST
West Pharmaceutical Services, Inc.
|
$293.5M | $173.7M | 15.73% | 17.44% | 21.6% | $133.9M |
Boston Scientific Corp. vs. Competitors
-
Which has Higher Returns BSX or ABT?
Abbott Laboratories has a net margin of 14.91% compared to Boston Scientific Corp.'s net margin of 14.07%. Boston Scientific Corp.'s return on equity of 12.46% beat Abbott Laboratories's return on equity of 29.06%.
Company Gross Margin Earnings Per Share Invested Capital BSXBoston Scientific Corp.65.31% $0.50 $35.7B ABTAbbott Laboratories52.05% $0.91 $64.2B -
What do Analysts Say About BSX or ABT?
Boston Scientific Corp. has a consensus price target of $126.48, signalling upside risk potential of 28.32%. On the other hand Abbott Laboratories has an analysts' consensus of $144.43 which suggests that it could grow by 15.28%. Given that Boston Scientific Corp. has higher upside potential than Abbott Laboratories, analysts believe Boston Scientific Corp. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings BSXBoston Scientific Corp.25 2 0 ABTAbbott Laboratories15 7 0 -
Is BSX or ABT More Risky?
Boston Scientific Corp. has a beta of 0.673, which suggesting that the stock is 32.691% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.716, suggesting its less volatile than the S&P 500 by 28.412%.
-
Which is a Better Dividend Stock BSX or ABT?
Boston Scientific Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 1.88% to investors and pays a quarterly dividend of $0.59 per share. Boston Scientific Corp. pays -- of its earnings as a dividend. Abbott Laboratories pays out 29.33% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BSX or ABT?
Boston Scientific Corp. quarterly revenues are $5.1B, which are smaller than Abbott Laboratories quarterly revenues of $11.4B. Boston Scientific Corp.'s net income of $755M is lower than Abbott Laboratories's net income of $1.6B. Notably, Boston Scientific Corp.'s price-to-earnings ratio is 52.72x while Abbott Laboratories's PE ratio is 15.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Boston Scientific Corp. is 7.61x versus 5.00x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSXBoston Scientific Corp.7.61x 52.72x $5.1B $755M ABTAbbott Laboratories5.00x 15.72x $11.4B $1.6B
-
Which has Higher Returns BSX or ELUT?
Elutia, Inc. has a net margin of 14.91% compared to Boston Scientific Corp.'s net margin of -11.53%. Boston Scientific Corp.'s return on equity of 12.46% beat Elutia, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BSXBoston Scientific Corp.65.31% $0.50 $35.7B ELUTElutia, Inc.55.76% -$0.19 -$5.4M -
What do Analysts Say About BSX or ELUT?
Boston Scientific Corp. has a consensus price target of $126.48, signalling upside risk potential of 28.32%. On the other hand Elutia, Inc. has an analysts' consensus of $4.00 which suggests that it could grow by 519.68%. Given that Elutia, Inc. has higher upside potential than Boston Scientific Corp., analysts believe Elutia, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings BSXBoston Scientific Corp.25 2 0 ELUTElutia, Inc.2 0 0 -
Is BSX or ELUT More Risky?
Boston Scientific Corp. has a beta of 0.673, which suggesting that the stock is 32.691% less volatile than S&P 500. In comparison Elutia, Inc. has a beta of 0.630, suggesting its less volatile than the S&P 500 by 37.049%.
-
Which is a Better Dividend Stock BSX or ELUT?
Boston Scientific Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Elutia, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Boston Scientific Corp. pays -- of its earnings as a dividend. Elutia, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSX or ELUT?
Boston Scientific Corp. quarterly revenues are $5.1B, which are larger than Elutia, Inc. quarterly revenues of $3.3M. Boston Scientific Corp.'s net income of $755M is higher than Elutia, Inc.'s net income of -$383K. Notably, Boston Scientific Corp.'s price-to-earnings ratio is 52.72x while Elutia, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Boston Scientific Corp. is 7.61x versus 1.31x for Elutia, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSXBoston Scientific Corp.7.61x 52.72x $5.1B $755M ELUTElutia, Inc.1.31x -- $3.3M -$383K
-
Which has Higher Returns BSX or ISRG?
Intuitive Surgical, Inc. has a net margin of 14.91% compared to Boston Scientific Corp.'s net margin of 28.31%. Boston Scientific Corp.'s return on equity of 12.46% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.
Company Gross Margin Earnings Per Share Invested Capital BSXBoston Scientific Corp.65.31% $0.50 $35.7B ISRGIntuitive Surgical, Inc.66.36% $1.95 $17B -
What do Analysts Say About BSX or ISRG?
Boston Scientific Corp. has a consensus price target of $126.48, signalling upside risk potential of 28.32%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $592.96 which suggests that it could grow by 4.08%. Given that Boston Scientific Corp. has higher upside potential than Intuitive Surgical, Inc., analysts believe Boston Scientific Corp. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BSXBoston Scientific Corp.25 2 0 ISRGIntuitive Surgical, Inc.15 10 1 -
Is BSX or ISRG More Risky?
Boston Scientific Corp. has a beta of 0.673, which suggesting that the stock is 32.691% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.
-
Which is a Better Dividend Stock BSX or ISRG?
Boston Scientific Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Boston Scientific Corp. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSX or ISRG?
Boston Scientific Corp. quarterly revenues are $5.1B, which are larger than Intuitive Surgical, Inc. quarterly revenues of $2.5B. Boston Scientific Corp.'s net income of $755M is higher than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, Boston Scientific Corp.'s price-to-earnings ratio is 52.72x while Intuitive Surgical, Inc.'s PE ratio is 75.41x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Boston Scientific Corp. is 7.61x versus 21.55x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSXBoston Scientific Corp.7.61x 52.72x $5.1B $755M ISRGIntuitive Surgical, Inc.21.55x 75.41x $2.5B $709.2M
-
Which has Higher Returns BSX or SOLV?
Solventum Corp. has a net margin of 14.91% compared to Boston Scientific Corp.'s net margin of 60.4%. Boston Scientific Corp.'s return on equity of 12.46% beat Solventum Corp.'s return on equity of 42.2%.
Company Gross Margin Earnings Per Share Invested Capital BSXBoston Scientific Corp.65.31% $0.50 $35.7B SOLVSolventum Corp.53.91% $7.22 $10.1B -
What do Analysts Say About BSX or SOLV?
Boston Scientific Corp. has a consensus price target of $126.48, signalling upside risk potential of 28.32%. On the other hand Solventum Corp. has an analysts' consensus of $84.36 which suggests that it could fall by -1.04%. Given that Boston Scientific Corp. has higher upside potential than Solventum Corp., analysts believe Boston Scientific Corp. is more attractive than Solventum Corp..
Company Buy Ratings Hold Ratings Sell Ratings BSXBoston Scientific Corp.25 2 0 SOLVSolventum Corp.3 7 1 -
Is BSX or SOLV More Risky?
Boston Scientific Corp. has a beta of 0.673, which suggesting that the stock is 32.691% less volatile than S&P 500. In comparison Solventum Corp. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock BSX or SOLV?
Boston Scientific Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Boston Scientific Corp. pays -- of its earnings as a dividend. Solventum Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BSX or SOLV?
Boston Scientific Corp. quarterly revenues are $5.1B, which are larger than Solventum Corp. quarterly revenues of $2.1B. Boston Scientific Corp.'s net income of $755M is lower than Solventum Corp.'s net income of $1.3B. Notably, Boston Scientific Corp.'s price-to-earnings ratio is 52.72x while Solventum Corp.'s PE ratio is 9.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Boston Scientific Corp. is 7.61x versus 1.77x for Solventum Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSXBoston Scientific Corp.7.61x 52.72x $5.1B $755M SOLVSolventum Corp.1.77x 9.81x $2.1B $1.3B
-
Which has Higher Returns BSX or WST?
West Pharmaceutical Services, Inc. has a net margin of 14.91% compared to Boston Scientific Corp.'s net margin of 17.41%. Boston Scientific Corp.'s return on equity of 12.46% beat West Pharmaceutical Services, Inc.'s return on equity of 17.44%.
Company Gross Margin Earnings Per Share Invested Capital BSXBoston Scientific Corp.65.31% $0.50 $35.7B WSTWest Pharmaceutical Services, Inc.36.49% $1.93 $3.4B -
What do Analysts Say About BSX or WST?
Boston Scientific Corp. has a consensus price target of $126.48, signalling upside risk potential of 28.32%. On the other hand West Pharmaceutical Services, Inc. has an analysts' consensus of $346.07 which suggests that it could grow by 21.72%. Given that Boston Scientific Corp. has higher upside potential than West Pharmaceutical Services, Inc., analysts believe Boston Scientific Corp. is more attractive than West Pharmaceutical Services, Inc..
Company Buy Ratings Hold Ratings Sell Ratings BSXBoston Scientific Corp.25 2 0 WSTWest Pharmaceutical Services, Inc.11 3 0 -
Is BSX or WST More Risky?
Boston Scientific Corp. has a beta of 0.673, which suggesting that the stock is 32.691% less volatile than S&P 500. In comparison West Pharmaceutical Services, Inc. has a beta of 1.166, suggesting its more volatile than the S&P 500 by 16.617%.
-
Which is a Better Dividend Stock BSX or WST?
Boston Scientific Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. West Pharmaceutical Services, Inc. offers a yield of 0.3% to investors and pays a quarterly dividend of $0.22 per share. Boston Scientific Corp. pays -- of its earnings as a dividend. West Pharmaceutical Services, Inc. pays out 12.27% of its earnings as a dividend. West Pharmaceutical Services, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios BSX or WST?
Boston Scientific Corp. quarterly revenues are $5.1B, which are larger than West Pharmaceutical Services, Inc. quarterly revenues of $804.3M. Boston Scientific Corp.'s net income of $755M is higher than West Pharmaceutical Services, Inc.'s net income of $140M. Notably, Boston Scientific Corp.'s price-to-earnings ratio is 52.72x while West Pharmaceutical Services, Inc.'s PE ratio is 42.11x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Boston Scientific Corp. is 7.61x versus 6.86x for West Pharmaceutical Services, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BSXBoston Scientific Corp.7.61x 52.72x $5.1B $755M WSTWest Pharmaceutical Services, Inc.6.86x 42.11x $804.3M $140M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
51
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
65
Is AAPL Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 38x
Buy
69
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
47
PSTG alert for Dec 4
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
41
SMX alert for Dec 4
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
43
HY alert for Dec 4
Hyster-Yale, Inc. [HY] is up 1.92% over the past day.
